UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000043922
Receipt No. R000050152
Scientific Title Clinicopathological differences between small and large T1 colorectal cancer
Date of disclosure of the study information 2021/04/16
Last modified on 2021/04/14 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Clinicopathological differences between small and large T1 colorectal cancer
Acronym Clinicopathological differences between small and large T1 colorectal cancer
Scientific Title Clinicopathological differences between small and large T1 colorectal cancer
Scientific Title:Acronym Clinicopathological differences between small and large T1 colorectal cancer
Region
Japan

Condition
Condition early colorectal cancer
Classification by specialty
Gastroenterology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 The aim of the present study is to compare the clinicopathological features of small and large T1 colorectal cancers.
Basic objectives2 Bio-equivalence
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Clinicopathological features included patient age, sex, initial treatment, tumor size, morphology, invasion depth, histological grade, lymphatic invasion, vascular invasion, tumor budding, and lymph node metastasis.
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria T1 colorectal cancers undergoing surgicaland endoscopic resection
Key exclusion criteria Cases of familial adenomatous polyposis, Lynch syndrome, ulcerative colitis, synchronous invasive carcinoma
Target sample size 1150

Research contact person
Name of lead principal investigator
1st name Yuki
Middle name
Last name Takashina
Organization Showa University Northern Yokohama Hospital
Division name Digestive Disease Center
Zip code 224-8503
Address 35-1, Chigasakityuo, Tsuzuki-ku, Yokohama, Japan
TEL 0459497000
Email y_takashina2011@yahoo.co.jp

Public contact
Name of contact person
1st name Yuki
Middle name
Last name Takashina
Organization Showa University Northern Yokohama Hospital
Division name Digestive Disease Center
Zip code 224-8503
Address 35-1, Chigasakityuo, Tsuzuki-ku, Yokohama, Japan
TEL 0459497000
Homepage URL
Email y_takashina2011@yahoo.co.jp

Sponsor
Institute Digestive Disease Center, Showa University Northern Yokohama Hospital
Institute
Department

Funding Source
Organization Nothing
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Institutional Review Board in Showa University Northern Yokohama Hospital,
Address 35-1, Chigasakityuo, Tsuzuki-ku, Yokohama, Japan
Tel 0459497000
Email y_takashina2011@yahoo.co.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 昭和大学横浜市北部病院 消化器センター

Other administrative information
Date of disclosure of the study information
2021 Year 04 Month 16 Day

Related information
URL releasing protocol
Publication of results Partially published

Result
URL related to results and publications
Number of participants that the trial has enrolled 1150
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2019 Year 12 Month 18 Day
Date of IRB
2020 Year 01 Month 07 Day
Anticipated trial start date
2020 Year 01 Month 07 Day
Last follow-up date
2022 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information The subjects were 1,152 patients with colorectal T1 cancer who underwent endoscopic or surgical resection at our center. Of these, 116 were small T1 cancers (<10mm) and 1036 were large T1 cancers (>10mm). The clinicopathological characteristics (age, sex, tumor size, gross type, SM invasiveness, histological type, lymphatic invasion, venous invasion, grouping, lymph node metastasis, and initial treatment) were compared between the two groups.

Management information
Registered date
2021 Year 04 Month 14 Day
Last modified on
2021 Year 04 Month 14 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050152